Latest rheumatoid arthritis Stories
LONDON, March 30, 2015 /PRNewswire/ -- This BCC Research report estimates the global diagnostics market for autoimmune diseases, with CAGR projections for the period 2014 to 2019.
-- Subsequent entry biologic (SEB) medicine provides a lower-cost, high-quality, safe and effective therapy for rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA)
Market Publishers Ltd informs that new reports by GlobalData have been recently uploaded to its catalogue. London, UK (PRWEB) March 25, 2015 Market Publishers
Simponi (golimumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 LONDON, March 26, 2015 /PRNewswire/ -- SummaryRheumatoid arthritis (RA) is a chronic
LONDON, March 26, 2015 /PRNewswire/ -- SummaryRheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints.
Legislation would lower out-of-pocket drug costs for Americans with chronic diseases PORTLAND, Ore., March 26, 2015 /PRNewswire-USNewswire/ -- Americans with chronic diseases like
Mediaplanet and Chef Seamus Mullen Launch “Bones and Joint Health” Campaign New York, NY (PRWEB) March 24, 2015 Mediaplanet is pleased to announce
LAS VEGAS, March 24, 2015 /PRNewswire-USNewswire/ -- Diabetes and previous joint pain, along with a patient's overall physical health status, may predict
DALLAS, March 19, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "PharmaPoint: Rheumatoid Arthritis - US and 5EU Drug Forecast and Market Analysis to 2023" report provides
Patented blood test to be used in clinical trials and as a companion diagnostic for Can-Fite's Drugs PETACH TIKVA, Israel, March 18, 2015 /PRNewswire/ --